Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 788 across all filing types
Latest filing 2023-05-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
关于参加河北辖区上市公司2023年投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement about the company's participation in an investor collective reception day event organized by regulatory and industry bodies. It mentions the date and format of the event and topics to be discussed, such as 2022 annual performance, governance, strategy, financing plans, and sustainability. The document is short (574 characters) and serves as a notice of an upcoming investor interaction event rather than a detailed report or transcript. It does not contain financial statements, audit information, or voting results. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-05-26 Chinese
关于康医转债回售的第二次提示性公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the repurchase (回售) of convertible bonds (可转债) issued by 康泰医学系统（秦皇岛）股份有限公司. It includes specific dates for the repurchase period, pricing, conditions triggering the repurchase right, procedures for bondholders to exercise their rights, and payment details. The document references regulatory requirements from the Shenzhen Stock Exchange and the company's bond issuance prospectus. It is not a financial report, earnings release, or management discussion but a formal notification about bondholders' rights and the company's bond repurchase process. The document length is 3269 characters, which is relatively short and focused on a specific capital/financing event. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-05-25 Chinese
关于康医转债暂停转股的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the suspension and resumption of convertible bond conversion rights for a specific bond issued by 康泰医学系统（秦皇岛）股份有限公司. It includes details about bond codes, dates for conversion suspension and resumption, regulatory approvals, and references to related announcements. The document is only 1232 characters long and does not contain financial statements or detailed financial data. It is an update on capital market activity related to convertible bonds, specifically about the temporary suspension of conversion rights during a bond repurchase period. This fits the category of Capital/Financing Update (CAP) rather than a full financial report or regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2023-05-22 Chinese
关于康医转债回售的第一次提示性公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the first reminder for the repurchase (回售) of convertible bonds (康医转债) issued by 康泰医学系统（秦皇岛）股份有限公司. It includes specific dates for the repurchase application period, repurchase price, conditions triggering the repurchase right, and procedural details. The document references regulatory requirements from the Shenzhen Stock Exchange and the company's bond issuance prospectus. It is not a financial report, earnings release, or management discussion but a formal notification about bondholders' rights to sell back their bonds under certain conditions. The document length is 3236 characters, which is relatively short and focused on a specific capital/financing event. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-05-22 Chinese
北京市长安律师事务所关于康泰医学系统（秦皇岛）股份有限公司可转换公司债券回售的法律意见书
Capital/Financing Update Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the repurchase (回售) of convertible bonds by 康泰医学系统（秦皇岛）股份有限公司. It discusses the legal basis, approvals, regulatory compliance, and conditions related to the convertible bond repurchase. It is not a financial report, earnings release, or management discussion. It is a standalone legal opinion related to a specific financing event (convertible bond repurchase). This fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document length is about 4200 characters, which is consistent with a detailed legal opinion rather than a brief announcement or a full report. Therefore, the classification is CAP with high confidence.
2023-05-22 Chinese
第四届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the first meeting of the fourth Supervisory Board of Kangtai Medical System (Qinhuangdao) Co., Ltd. It details the election of the Supervisory Board chairman and confirms the meeting's compliance with legal and regulatory requirements. There is no financial data, audit information, or report content. It is an announcement related to board/management information, specifically about the Supervisory Board's composition and leadership. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication or certification, so it is not RPA or RNS.
2023-05-19 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.